Trial intelligence / Profile preview

FACT: Febuxostat vs Allopurinol in Gout

NCT00102440Phase 3Completed

Sponsor
Takeda
Start
Jul 2002
Primary completion
Feb 2004
Modality
Small Molecules
01

Overview

A Phase 3 trial of febuxostat in gout, sponsored by Takeda. Started Jul 2002; status: completed.

02

Drugs

febuxostat
03

Conditions

gout

Beyond the preview

Go deeper on NCT00102440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00102440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call